Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Indy Hematology Review
S

DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remission After Initial Therapy

By Indy Hematology Review FEATURING Saad Usmani
By Indy Hematology Review FEATURING Saad Usmani
318 views
April 19, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Myeloma
16:42
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…

Feat. H. Hashmi
15:21
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Frontline Treatment for High-Risk MM - Personalized?

Feat. S. Usmani
31:51
Indy Hematology Review

Managing Newly Diagnosed MM in 2023

Feat. S. Usmani
15:53
Indy Hematology Review

DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remissi…

Feat. S. Usmani
10:08
ASH 2022 Conference Coverage

ASH 2022 Maintenance Therapy Cessation for Sustained MRD Negative MM…

Feat. N. Korde
34:28
2022 Community Oncology Conference

Treatment Conundrums in Myeloma

Feat. S. Giralt
20:17
Rush University Medical Center

High-Risk Myeloma: Failures and Future Directions

Feat. S. Usmani
11:51
Memorial Sloan Kettering Cancer Center

Aiming for Minimal Residual Disease Negative Status in all Myeloma P…

Feat. O. Landgren
19:16
Memorial Sloan Kettering Cancer Center

Should Smoldering Myeloma Be Treated?

Feat. O. Landgren
47:00
Memorial Sloan Kettering Cancer Center

Common Symptoms and Presentations of Multiple Myeloma to Primary Car…

Feat. O. Landgren